Experts in the field of healthcare are emphasizing the importance of keeping states informed about clinical trials in India. Clinical trials play a significant role in the development of new drugs and treatment methods, and it is crucial for states to be aware of these trials to ensure proper regulation and oversight. According to experts, transparency and communication between the central government, state governments, and regulatory bodies are essential to ensure the safety and efficacy of clinical trials. In India, the Drug Controller General of India (DCGI) is responsible for regulating clinical trials, but experts believe that states should also be actively involved in the process to safeguard the interests of their residents. By keeping states informed about ongoing clinical trials, authorities can ensure that proper guidelines are followed, and participants are protected from any potential risks. Additionally, involving states in the oversight of clinical trials can help build trust and confidence among the public regarding the healthcare system. Overall, experts are calling for better coordination and communication between all stakeholders involved in clinical trials to maintain high standards of ethics and safety in medical research.